Glaucoma Surgery Redefined
By Eric D. Donnenfeld, MD
By David R. Hardten, MD; Parag A. Majmudar, MD; J. E. “Jay” McDonald II, MD; and Jeffrey Whitman, MD
By Elena Albé, MD
By Mitchell C. Shultz, MD
By William J. Fishkind, MD; James C. Loden, MD; R. Bruce Wallace III, MD; and Robert J. Weinstock, MD
By Alan S. Crandall, MD; Devin M. Gattey, MD; Howard V. Gimbel, MD; and Thomas A. Oetting, MS, MD
By Terry Kim, MD, and Matthew D. Kuhnle, DO
Allowing partially detached grafts the chance to clear spontaneously is often best.
By Jack S. Parker, BA, and Gerrit R. J. Melles, MD, PhD
Surgeons should consider the Big Four: tears, lids, blinks, and sensation.
By Kenneth R. Kenyon, MD
Determine if the condition is mild, moderate, or severe before making a recommendation.
By Henry D. Perry, MD
Surgeons should make use of available testing modalities.
By Marguerite B. McDonald, MD
A practical approach to prevention.
By Tom Pannullo
Quite a lot, thank you, and so are you!
By Michael E. Snyder, MD; Robert K. Maloney, MD; Derek W. DelMonte, MD; Terry Kim, MD; George O. Waring IV, MD; and Luis E. Fernández de Castro, MD
If demonstrated to be safe, this procedure may become a desirable option for patients who elect to pay privately for vision correction.
By Daniel S. Durrie, MD
Patients in Mongolia now have access to vitreoretinal services.
By Roger P. Harrie, MD
An engaging, informative health care blog can help physicians connect with patients and establish themselves as leaders in their profession.
By Cary M. Silverman, MD, MBA, and Shama Kabani
Detailed videos for patients save time when it comes to their final decision on an implant.
By Cynthia Matossian, MD
Dr. Colvard discusses his experience as an educator and how his work in undeveloped countries inspired the creation of the Friends of Vision Foundation.
Avedro, Inc., submitted a new drug application to the FDA for its 0.1% riboflavin ophthalmic solution (VibeX)/KXL System for the treatment of keratoconus and corneal ectasia following refractive surgery, according to a news rel... more >
Bausch + Lomb has announced that it will purchase Ista Pharmaceuticals, Inc., in a deal reported to be worth around $500 million. Under the terms to the agreement, which is expected to close in the second quarter of 2012, Ba... more >
Simulated outcomes in patients implanted with toric IOLs suggested that dual-zone keratometry performed with the Lenstar LS900 (Haag-Streit AG) is equivalent to manual keratometry, according to a study in the emJournal of Cata... more >
Heidelberg Engineering GmbH announced that the FDA has granted clearance for the Spectralis Anterior Segment Module. The new module of the Spectralis spectral-domain optical coherence tomography (OCT) system provides high-r... more >
Advertisement
Detailed videos for patients save time when it comes to their final decision on an implant.
By Cynthia Matossian, MD
By Terry Kim, MD, and Matthew D. Kuhnle, DO
By David R. Hardten, MD; Parag A. Majmudar, MD; J. E. “Jay” McDonald II, MD; and Jeffrey Whitman, MD
A practical approach to prevention.
By Tom Pannullo
By Elena Albé, MD